A synergistic anti-apoptotic effect has been observed for NGF/SCF and NT-3/SCF in human MCs [45,49]; thus, determining whether TRK signaling cooperates with KIT mutations in the induction of SM remains an important aspect for understanding mastocytosis development. This evidence concerns the gene NTRK1 and systemic mastocytosis.